Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Improve glycemic control with type 2 diabetes mellitus
Condition: Initial
Dose: Oral – 5 mg
Frequency: once daily in morning
Note: Indicated as an adjunct to diet and exercise to improve glycemic control with type 2 diabetes mellitus
Indication: Improve glycemic control with type 2 diabetes mellitus
Condition: Additional glycemic control required
Dose: Oral – 10 mg
Frequency: once daily
Note: May increase to 10 mg once daily in patients tolerating 5 mg/day who require additional glycemic control

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: Dose:
Note: Safety and efficacy not established

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment eGFR greater than 45 mL/min/1.73 m2
Dose: Not specified
Note: No dosage adjustment required
Indication: Type 2 Diabetes Mellitus
Condition: Renal impairment eGFR 25 to less than 45 mL/min/1.73 m2
Dose: Not specified
Note: Not recommended
Administration
  • Take in morning
  • Can take with or without food
Side Effect

Drug Interaction

Drug NameRisk Factors
Insulin, insulin secretagogues (e.g. sulfonylureas)
Hypoglycemia may occur with concomitant use
Rifampin
Decrease in Cmax & AUC

Disease Interaction

Disease NameRisk Factors
Drug Hypersensitivity
Risk of allergic reaction
Moderate to Severe Renal Impairment
Risk of kidney complications

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.